Novel Drug Approvals for 2018

No. Drug Name Active Ingredient Approval Date FDA-approved use on approval date 9. Akynzeo fosnetupitant and palonosetron 4/19/2018 To prevent acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy 8. Crysvita burosumab-twza